Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02409888
Other study ID # Pro2013003944
Secondary ID 1R01AA022330-01A
Status Completed
Phase N/A
First received
Last updated
Start date November 2015
Est. completion date July 31, 2021

Study information

Verified date August 2021
Source Rutgers, The State University of New Jersey
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to investigate how behavioral treatments for alcohol use disorders affect behavior change.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date July 31, 2021
Est. primary completion date June 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Study inclusion criteria are such that study participants must: 1. meet a Diagnostic and Statistical Manual-IV (DSM-IV) alcohol abuse or dependence diagnosis based on the Diagnostic Interview Schedule - IV (DIS-IV); 2. consume a weekly average of at least 24 standard drinks during the baseline period to include at least 5 episodes of heavy drinking; 3. agree not to seek additional alcohol or other substance abuse treatment during the study period; 4. be at least 18 years of age; and 5. be sufficiently proficient in their English speaking ability to interact effectively with the research interviewer. Exclusion Criteria: - Individuals assessed as having a drug diagnosis that is more severe than their alcohol diagnosis (e.g., cocaine dependence and alcohol abuse, IV drug use), - a serious psychiatric diagnosis (e.g., uncontrolled schizophrenia or major depression) as well as those meeting criteria for organic brain impairment, as measured by the mini-mental status examination section of the DIS-IV will be precluded from study participation. In addition, - individuals reporting current enrollment in a substance abuse treatment program, - mandated to substance abuse treatment by a court order, or - severely socially unstable (e.g., homeless) also will be precluded from study participation.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Motivational Enhancement Therapy
The motivational enhancement therapy will be delivered according to the Project MATCH manual.
Cognitive Behavioral Therapy
The cognitive behavioral therapy will be delivered according to the Project MATCH manual.
Other:
FC Assessment
FC Assessment study participants are exposed to quarterly assessments across broad domains of functioning.
IB Assessment
IB Assessment study participants are exposed to semi-annual alcohol specific assessments

Locations

Country Name City State
United States Rutgers University School of Public Health New Brunswick New Jersey

Sponsors (4)

Lead Sponsor Collaborator
Rutgers, The State University of New Jersey National Institute on Alcohol Abuse and Alcoholism (NIAAA), Pacific Institute for Research and Evaluation, Syracuse University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Alcohol Use Alcohol use will be measured as percent days abstinent, mean drinks per drinking day, and percent heavy drinking days for study months 3 - 15 (one year post-treatment). One year post-treatment
See also
  Status Clinical Trial Phase
Recruiting NCT05054738 - CRP and S&A for Inpatient Veterans N/A
Completed NCT02233738 - Group Motivational Interviewing (GMI) For Homeless Veterans In VA Services N/A
Completed NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Completed NCT00000437 - Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone) Phase 4
Completed NCT00536146 - The Stress-Hormone System in Alcohol-Dependent Subjects N/A
Terminated NCT00890149 - Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults Phase 2
Completed NCT02939352 - The Effects of Theta Burst Stimulation on the Brain Response to Drug and Alcohol Cues Early Phase 1
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Completed NCT01389297 - Overcoming Addictions: A Randomized Clinical Trial of a Web Application Based on SMART Recovery N/A
Completed NCT01113164 - Matching Genotypes and Serotonergic Medications for Alcoholism Phase 1
Completed NCT01760785 - Valproate for Mood Swings and Alcohol Use Following Head Injury N/A
Completed NCT00768508 - Combined Pharmacotherapies for Alcoholism Phase 3
Completed NCT00127231 - Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women N/A
Terminated NCT02842528 - Cognitive Vulnerability Factors in Alcohol-dependence N/A
Completed NCT00367575 - An Internet-based Intervention for Problem Drinking N/A
Completed NCT00223639 - New Medications to Treat Alcohol Dependence Phase 2
Completed NCT00583440 - 12-step Facilitation for the Dually Diagnosed Phase 1/Phase 2
Completed NCT00167687 - Prazosin Alcohol Dependence IVR Study Phase 4